Skip to main content
Addgene

FH-TET1-pEF Citations (21)

Originally described in: Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1.
Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, Rao A Science. 2009 May 15;324(5929):930-5. Epub 2009 Apr 16. PubMed Journal

Articles Citing FH-TET1-pEF

Articles
MiR-520b suppresses proliferation of hepatoma cells through targeting ten-eleven translocation 1 (TET1) mRNA. Zhang W, Lu Z, Gao Y, Ye L, Song T, Zhang X. Biochem Biophys Res Commun. 2015 May 8;460(3):793-8. doi: 10.1016/j.bbrc.2015.03.108. Epub 2015 Mar 28. PubMed
GADD45a physically and functionally interacts with TET1. Kienhofer S, Musheev MU, Stapf U, Helm M, Schomacher L, Niehrs C, Schafer A. Differentiation. 2015 Jul-Oct;90(1-3):59-68. doi: 10.1016/j.diff.2015.10.003. Epub 2015 Nov 3. PubMed
CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter. Choudhury SR, Cui Y, Lubecka K, Stefanska B, Irudayaraj J. Oncotarget. 2016 Jun 23. doi: 10.18632/oncotarget.10234. PubMed
Association of TET1 expression with colorectal cancer progression. Tian Y, Pan F, Sun X, Gan M, Lin A, Zhang D, Zhu Y, Lai M. Scand J Gastroenterol. 2017 Mar;52(3):312-320. doi: 10.1080/00365521.2016.1253767. Epub 2016 Nov 16. PubMed
TET1 promotes cisplatin-resistance via demethylating the vimentin promoter in ovarian cancer. Han X, Zhou Y, You Y, Lu J, Wang L, Hou H, Li J, Chen W, Zhao L, Li X. Cell Biol Int. 2017 Apr;41(4):405-414. doi: 10.1002/cbin.10734. Epub 2017 Feb 16. PubMed
TET1 inhibits EMT of ovarian cancer cells through activating Wnt/beta-catenin signaling inhibitors DKK1 and SFRP2. Duan H, Yan Z, Chen W, Wu Y, Han J, Guo H, Qiao J. Gynecol Oncol. 2017 Nov;147(2):408-417. doi: 10.1016/j.ygyno.2017.08.010. Epub 2017 Aug 26. PubMed
Oxygen gradients can determine epigenetic asymmetry and cellular differentiation via differential regulation of Tet activity in embryonic stem cells. Burr S, Caldwell A, Chong M, Beretta M, Metcalf S, Hancock M, Arno M, Balu S, Kropf VL, Mistry RK, Shah AM, Mann GE, Brewer AC. Nucleic Acids Res. 2018 Feb 16;46(3):1210-1226. doi: 10.1093/nar/gkx1197. PubMed
The contribution of active and passive mechanisms of 5mC and 5hmC removal in human T lymphocytes is differentiation- and activation-dependent. Vincenzetti L, Leoni C, Chirichella M, Kwee I, Monticelli S. Eur J Immunol. 2019 Jan 30. doi: 10.1002/eji.201847967. PubMed

Associated Plasmids
Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer. Yu Y, Qi J, Xiong J, Jiang L, Cui D, He J, Chen P, Li L, Wu C, Ma T, Shao S, Wang J, Yu D, Zhou B, Huang D, Schmitt CA, Tao R. Theranostics. 2019 Jan 24;9(3):761-777. doi: 10.7150/thno.29520. eCollection 2019. PubMed
Hydroxyurea promotes TET1 expression and induces apoptosis in osteosarcoma cells. Teng S, Ma C, Yu Y, Yi C. Biosci Rep. 2019 May 14;39(5). pii: BSR20190456. doi: 10.1042/BSR20190456. Print 2019 May 31. PubMed
Chrysin Induced Cell Apoptosis and Inhibited Invasion Through Regulation of TET1 Expression in Gastric Cancer Cells. Zhong X, Liu D, Jiang Z, Li C, Chen L, Xia Y, Liu D, Yao Q, Wang D. Onco Targets Ther. 2020 Apr 20;13:3277-3287. doi: 10.2147/OTT.S246031. eCollection 2020. PubMed
H19/TET1 axis promotes TGF-beta signaling linked to endothelial-to-mesenchymal transition. Cao T, Jiang Y, Li D, Sun X, Zhang Y, Qin L, Tellides G, Taylor HS, Huang Y. FASEB J. 2020 Jun;34(6):8625-8640. doi: 10.1096/fj.202000073RRRRR. Epub 2020 May 6. PubMed
Quantitative analysis of global 5-methyl- and 5-hydroxymethylcytosine in TET1 expressed HEK293T cells. Kojima N, Suda T, Fujii S, Hirano K, Namihira M, Kurita R. Biosens Bioelectron. 2020 Nov 1;167:112472. doi: 10.1016/j.bios.2020.112472. Epub 2020 Jul 28. PubMed
Unraveling the functional role of DNA demethylation at specific promoters by targeted steric blockage of DNA methyltransferase with CRISPR/dCas9. Sapozhnikov DM, Szyf M. Nat Commun. 2021 Sep 29;12(1):5711. doi: 10.1038/s41467-021-25991-9. PubMed

Associated Plasmids
Regulation of Ion Channel Function in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Cancer Cell Secretion Through DNA Methylation. Zhong R, Zhang F, Yang Z, Li Y, Xu Q, Lan H, Lang S, Cyganek L, Burgermeister E, El-Battrawy I, Zhou X, Akin I, Borggrefe M. Front Cardiovasc Med. 2022 Feb 21;9:839104. doi: 10.3389/fcvm.2022.839104. eCollection 2022. PubMed
Multiplexed Assembly and Annotation of Synthetic Biology Constructs Using Long-Read Nanopore Sequencing. Emiliani FE, Hsu I, McKenna A. ACS Synth Biol. 2022 Jul 15;11(7):2238-2246. doi: 10.1021/acssynbio.2c00126. Epub 2022 Jun 13. PubMed
Optochemical Control of TET Dioxygenases Enables Kinetic Insights into the Domain-Dependent Interplay of TET1 and MBD1 while Oxidizing and Reading 5-Methylcytosine. Lin TC, Palei S, Summerer D. ACS Chem Biol. 2022 Jul 15;17(7):1844-1852. doi: 10.1021/acschembio.2c00245. Epub 2022 Jun 16. PubMed
TET1 dioxygenase is required for FOXA2-associated chromatin remodeling in pancreatic beta-cell differentiation. Li J, Wu X, Ke J, Lee M, Lan Q, Li J, Yu J, Huang Y, Sun DQ, Xie R. Nat Commun. 2022 Jul 7;13(1):3907. doi: 10.1038/s41467-022-31611-x. PubMed
Reactivity-dependent profiling of RNA 5-methylcytidine dioxygenases. Arguello AE, Li A, Sun X, Eggert TW, Mairhofer E, Kleiner RE. Nat Commun. 2022 Jul 19;13(1):4176. doi: 10.1038/s41467-022-31876-2. PubMed
Quercetin Mediated TET1 Expression Through MicroRNA-17 Induced Cell Apoptosis in Melanoma Cells. Gao Y, Li C, Xue T, Lin C, Hou R, Xia Q, Ding D, Li J, Wang D, Feng Y. Biochem Genet. 2023 Apr;61(2):762-777. doi: 10.1007/s10528-022-10286-5. Epub 2022 Sep 22. PubMed
TET1 inhibits the migration and invasion of cervical cancer cells by regulating autophagy. Ren J, Chen X, Li J, Zan Y, Wang S, Tan Y, Ding Y. Epigenetics. 2024 Dec;19(1):2323751. doi: 10.1080/15592294.2024.2323751. Epub 2024 Mar 3. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.